Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by eric40on Jan 27, 2021 10:05pm
152 Views
Post# 32406299

RE:RE:Who pulls the plug just prior to an FDA decision ?

RE:RE:Who pulls the plug just prior to an FDA decision ?It reminds me what they did with IVIG 2 years ago. Wash/rinse /repeat. They got away with it ruining thousands of investors and they do the same now.

Except it is even worst now since Ryplazim has a PDUFA date of june 5 2021 in less than 4 months. And they resubmit the BLA helped with external expert so obviously RYPLAZIM SHOULD BE APPROVED BY JUNE 5 WITHIN THE NEXT FOR MONTHS!

They already know all the patients who will buy Ryplazim because it is a small pool of patient and they already did everythings with inssurance company for reimbursing Ryplazim. 

SO THEY DON'T EVEN HAVE TO PARTNER OR HAVE  A MARKETING TEAM to sell Ryplazim

As soon as it is approved, it will sell easy. And there is a very possible Voucher that will come with the approval of Ryplazim that will worth tens of millions, even a hundred milion.

So as this post says, who pull the plug prior an FDA decision?
Who announce a news to crash a company on purpose since they could simply have pause the company until approval with no cash burn?

Obviously, they want to wipe the value and then go private and keep the money.

They did the same 2 years ago. Climinal ...Criminal
<< Previous
Bullboard Posts
Next >>